<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004172A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004172</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13536851</doc-number><date>20120628</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>127</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>P</subclass><main-group>25</main-group><subgroup>00</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>38</main-group><subgroup>17</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>P</subclass><main-group>25</main-group><subgroup>28</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classification-national><country>US</country><main-classification>424450</main-classification><further-classification>514 177</further-classification><further-classification>514 178</further-classification></classification-national><invention-title id="d0e43">LIPOSOMES ACTIVE IN-VIVO ON NEURODEGENERATIVE DISEASES</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>MASSERINI</last-name><first-name>Massimo</first-name><address><city>Santa Margherita Ligure (GE)</city><country>IT</country></address></addressbook><residence><country>IT</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>RE</last-name><first-name>Francesca</first-name><address><city>Busto Garolfo (MI)</city><country>IT</country></address></addressbook><residence><country>IT</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>SANCINI</last-name><first-name>Giulio</first-name><address><city>Gessate (MI)</city><country>IT</country></address></addressbook><residence><country>IT</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>FORLONI</last-name><first-name>Gianluigi</first-name><address><city>Rho (MI)</city><country>IT</country></address></addressbook><residence><country>IT</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>SALMONA</last-name><first-name>Mario</first-name><address><city>Milano</city><country>IT</country></address></addressbook><residence><country>IT</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>MASSERINI</last-name><first-name>Massimo</first-name><address><city>Santa Margherita Ligure (GE)</city><country>IT</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>RE</last-name><first-name>Francesca</first-name><address><city>Busto Garolfo (MI)</city><country>IT</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>SANCINI</last-name><first-name>Giulio</first-name><address><city>Gessate (MI)</city><country>IT</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>FORLONI</last-name><first-name>Gianluigi</first-name><address><city>Rho (MI)</city><country>IT</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>SALMONA</last-name><first-name>Mario</first-name><address><city>Milano</city><country>IT</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">New liposomes are described, comprising: (i) phosphatidic acid and/or cardiolipin; (ii) apolipoprotein E (ApoE) or derivatives thereof. The so modified liposomes, administered systemically, obtain a dramatic in-vivo reduction of the amyloid plaque in the central nervous system, allowing an effective treatment of neurodegenerative diseases, in particular Alzheimer's disease.</p></abstract></us-patent-application>